[Hemosorption treatment of patients with atherosclerotic encephalopathy]. 1985

A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov

A total of 140 patients with atherosclerotic encephalopathy were subjected to a multiple modality treatment. The efficiency of the treatment with (n-90) and without (n-50) hemosorption was compared. The results of the treatment were assessed by neurologic and neuropsychological examinations, spectral analysis of the EEG and the study of blood lipids. Hemosorption was found to be highly effective in the treatment of patients with atherosclerotic encephalopathy, which was expressed in the regression of clinical manifestations, a positive time-course of the electrical activity of the brain and lipid metabolism indicators.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002537 Intracranial Arteriosclerosis Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS. Cerebral Arteriosclerosis,Intracranial Atherosclerosis,Cerebral Atherosclerosis,Arterioscleroses, Cerebral,Arterioscleroses, Intracranial,Arteriosclerosis, Cerebral,Arteriosclerosis, Intracranial,Atheroscleroses, Cerebral,Atheroscleroses, Intracranial,Atherosclerosis, Cerebral,Atherosclerosis, Intracranial,Cerebral Arterioscleroses,Cerebral Atheroscleroses,Intracranial Arterioscleroses,Intracranial Atheroscleroses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
January 1994, Klinicheskaia khirurgiia,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
April 1989, Vrachebnoe delo,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
May 1985, Vrachebnoe delo,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
January 1995, Likars'ka sprava,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
October 1986, Kardiologiia,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
January 1987, Vrachebnoe delo,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
January 1997, Likars'ka sprava,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
January 1987, Biomaterials, artificial cells, and artificial organs,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
May 1985, Vrachebnoe delo,
A I Fedin, and N D Lakosina, and E B Teterina, and O V Zhbankova, and V A Simonov
September 1987, Vrachebnoe delo,
Copied contents to your clipboard!